blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2507263

EP2507263 - ANTI-IGF-IR ANTIBODIES AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.07.2017
Database last updated on 25.09.2024
Most recent event   Tooltip19.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 21.11.2018  [2018/47]
Applicant(s)For all designated states
The University of Hong Kong
Pokfulam Road
Hong Kong / CN
[2012/41]
Inventor(s)01 / ZHANG, Meiyun
Flat 5, 5th Floor
Block A
Parkway Court
4 Park Road
Hong Kong / HK
 [2012/41]
Representative(s)Epping - Hermann - Fischer
Patentanwaltsgesellschaft mbH
Schloßschmidstraße 5
80639 München / DE
[2016/36]
Former [2012/41]Epping - Hermann - Fischer
Patentanwaltsgesellschaft mbH Ridlerstrasse 55
80339 München / DE
Application number, filing date10834154.606.12.2010
[2016/36]
WO2010CN01963
Priority number, dateUS20090266681P04.12.2009         Original published format: US 266681 P
[2012/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011066721
Date:09.06.2011
Language:EN
[2011/23]
Type: A1 Application with search report 
No.:EP2507263
Date:10.10.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 09.06.2011 takes the place of the publication of the European patent application.
[2012/41]
Type: B1 Patent specification 
No.:EP2507263
Date:07.09.2016
Language:EN
[2016/36]
Search report(s)International search report - published on:CN09.06.2011
(Supplementary) European search report - dispatched on:EP12.04.2013
ClassificationIPC:C07K16/28, C12N5/18, C12N15/13, A61K39/00, A61K39/395
[2012/41]
CPC:
C07K16/2863 (EP,US); A61P35/00 (EP); C07K2317/24 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/41]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ANTI-IGF-IR-ANTIKÖRPER UND IHRE VERWENDUNGEN[2012/41]
English:ANTI-IGF-IR ANTIBODIES AND USES THEREOF[2012/41]
French:ANTICORPS ANTI-IGF-IR ET LEURS UTILISATIONS[2012/41]
Entry into regional phase31.05.2012National basic fee paid 
31.05.2012Search fee paid 
31.05.2012Designation fee(s) paid 
31.05.2012Examination fee paid 
Examination procedure27.06.2011Request for preliminary examination filed
International Preliminary Examining Authority: CN
31.05.2012Examination requested  [2012/41]
12.11.2013Amendment by applicant (claims and/or description)
07.08.2015Despatch of a communication from the examining division (Time limit: M06)
23.12.2015Reply to a communication from the examining division
30.03.2016Communication of intention to grant the patent
25.07.2016Fee for grant paid
25.07.2016Fee for publishing/printing paid
25.07.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.08.2015
Opposition(s)08.06.2017No opposition filed within time limit [2017/33]
Fees paidRenewal fee
11.12.2012Renewal fee patent year 03
12.12.2013Renewal fee patent year 04
11.12.2014Renewal fee patent year 05
10.12.2015Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.12.2010
AL07.09.2016
AT07.09.2016
BE07.09.2016
CY07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
HR07.09.2016
IT07.09.2016
LT07.09.2016
LV07.09.2016
MC07.09.2016
MK07.09.2016
NL07.09.2016
PL07.09.2016
RO07.09.2016
RS07.09.2016
SE07.09.2016
SI07.09.2016
SK07.09.2016
SM07.09.2016
TR07.09.2016
IE06.12.2016
LU06.12.2016
MT06.12.2016
BG07.12.2016
NO07.12.2016
GR08.12.2016
IS07.01.2017
PT09.01.2017
[2018/47]
Former [2018/43]HU06.12.2010
AT07.09.2016
BE07.09.2016
CY07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
HR07.09.2016
IT07.09.2016
LT07.09.2016
LV07.09.2016
MC07.09.2016
MK07.09.2016
NL07.09.2016
PL07.09.2016
RO07.09.2016
RS07.09.2016
SE07.09.2016
SI07.09.2016
SK07.09.2016
SM07.09.2016
TR07.09.2016
IE06.12.2016
LU06.12.2016
MT06.12.2016
BG07.12.2016
NO07.12.2016
GR08.12.2016
IS07.01.2017
PT09.01.2017
Former [2018/29]HU06.12.2010
AT07.09.2016
BE07.09.2016
CY07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
HR07.09.2016
IT07.09.2016
LT07.09.2016
LV07.09.2016
MC07.09.2016
MK07.09.2016
NL07.09.2016
PL07.09.2016
RO07.09.2016
RS07.09.2016
SE07.09.2016
SI07.09.2016
SK07.09.2016
SM07.09.2016
TR07.09.2016
IE06.12.2016
LU06.12.2016
BG07.12.2016
NO07.12.2016
GR08.12.2016
IS07.01.2017
PT09.01.2017
Former [2018/28]HU06.12.2010
AT07.09.2016
BE07.09.2016
CY07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
HR07.09.2016
IT07.09.2016
LT07.09.2016
LV07.09.2016
MC07.09.2016
MK07.09.2016
NL07.09.2016
PL07.09.2016
RO07.09.2016
RS07.09.2016
SE07.09.2016
SI07.09.2016
SK07.09.2016
SM07.09.2016
IE06.12.2016
LU06.12.2016
BG07.12.2016
NO07.12.2016
GR08.12.2016
IS07.01.2017
PT09.01.2017
Former [2017/49]AT07.09.2016
BE07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
HR07.09.2016
IT07.09.2016
LT07.09.2016
LV07.09.2016
MC07.09.2016
NL07.09.2016
PL07.09.2016
RO07.09.2016
RS07.09.2016
SE07.09.2016
SI07.09.2016
SK07.09.2016
SM07.09.2016
IE06.12.2016
LU06.12.2016
BG07.12.2016
NO07.12.2016
GR08.12.2016
IS07.01.2017
PT09.01.2017
Former [2017/45]AT07.09.2016
BE07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
HR07.09.2016
IT07.09.2016
LT07.09.2016
LV07.09.2016
MC07.09.2016
NL07.09.2016
PL07.09.2016
RO07.09.2016
RS07.09.2016
SE07.09.2016
SI07.09.2016
SK07.09.2016
SM07.09.2016
BG07.12.2016
NO07.12.2016
GR08.12.2016
IS07.01.2017
PT09.01.2017
Former [2017/37]AT07.09.2016
BE07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
HR07.09.2016
IT07.09.2016
LT07.09.2016
LV07.09.2016
NL07.09.2016
PL07.09.2016
RO07.09.2016
RS07.09.2016
SE07.09.2016
SI07.09.2016
SK07.09.2016
SM07.09.2016
BG07.12.2016
NO07.12.2016
GR08.12.2016
IS07.01.2017
PT09.01.2017
Former [2017/34]AT07.09.2016
BE07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
HR07.09.2016
IT07.09.2016
LT07.09.2016
LV07.09.2016
NL07.09.2016
PL07.09.2016
RO07.09.2016
RS07.09.2016
SE07.09.2016
SK07.09.2016
SM07.09.2016
BG07.12.2016
NO07.12.2016
GR08.12.2016
IS07.01.2017
PT09.01.2017
Former [2017/32]AT07.09.2016
BE07.09.2016
CZ07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
HR07.09.2016
IT07.09.2016
LT07.09.2016
LV07.09.2016
NL07.09.2016
PL07.09.2016
RO07.09.2016
RS07.09.2016
SE07.09.2016
SK07.09.2016
SM07.09.2016
BG07.12.2016
NO07.12.2016
GR08.12.2016
IS07.01.2017
PT09.01.2017
Former [2017/13]ES07.09.2016
FI07.09.2016
HR07.09.2016
LT07.09.2016
LV07.09.2016
NL07.09.2016
RS07.09.2016
SE07.09.2016
NO07.12.2016
GR08.12.2016
Former [2017/11]ES07.09.2016
FI07.09.2016
HR07.09.2016
LT07.09.2016
RS07.09.2016
SE07.09.2016
NO07.12.2016
GR08.12.2016
Former [2017/10]FI07.09.2016
HR07.09.2016
LT07.09.2016
RS07.09.2016
SE07.09.2016
NO07.12.2016
Former [2017/09]FI07.09.2016
LT07.09.2016
NO07.12.2016
Former [2017/07]LT07.09.2016
Documents cited:Search[XI]  - MEI-YUN ZHANG ET AL, "Characterization of a chimeric monoclonal antibody against the insulin-like growth factor-I receptor", MABS, (20090901), vol. 1, no. 5, doi:10.4161/mabs.1.5.9580, ISSN 1942-0862, pages 475 - 480, XP055058186 [X] 1,3-6,8-11 * whole document, especially the Abstract; Figures 1 and 4 * [I] 2,7,12-16

DOI:   http://dx.doi.org/10.4161/mabs.1.5.9580
International search[X]WO2007012614  (PF MEDICAMENT [FR], et al);
 [X]CN101014625  (PF MEDICAMENT [FR]);
 [A]  - FENG L. ET AL, "Expression and clinic significance of IGF-IR in Breast Cancer tissue", JOURNAL OF MEDICAL FORUM, (200803), vol. 29, no. 5, pages 8 - 10, XP008160352
 [A]  - SUN, LIYAN ET AL, "Advancement in research on insulin-like growth factor in cancer metastasis", INTERNATIONAL JOURNAL OF INTERNAL MEDICINE, (200806), vol. 35, no. 6, pages 329 - 336, XP008160320
by applicant   - ZHANG ET AL., MABS, (2009), vol. 1, pages 475 - 480
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.